The Director of the Practice-Based Research Network DO-Touch.NET, Brian Degenhardt, DO, C-NMM/OMM, gives an update on our COVID-19 response.
Clinicians using OMT as part of their treatment for patients with COVID-19 interested in joining our study – https://is.gd/omt_covid19_optin
Information about joining DO-Touch.NET – https://www.do-touch.net/become-a-member/
Leave a comment below, and share our message with your social networks.
1 thought on “From The Director: Update on Our COVID-19 Response”
I do not have a hospital based practice and although I have contacted medical staff offering to treat Covid-19 patients, there is not a strong history of acceptance of OMT in my medical community. I expect that my contribution will come in treating people who survive the infection but who have lingering pulmonary effects. That, too, is a study that in my mind should be done as I anticipate lingering parenchymal impacts and pleural adhesions at a minimum in many of these patients.